Q2 2025 Else Nutrition Holdings Inc Earnings Call Transcript
Key Points
- Else Nutrition Holdings Inc (BABYF) has made significant progress in streamlining operations and retail distribution, which is expected to lead to cost savings and operational agility.
- The company is expanding its kids' ready-to-drink products within Walmart, now available in approximately 1,000 stores, indicating strong retail growth.
- Else Nutrition is actively involved in regulatory discussions, with encouraging developments in the US that could pave the way for their plant-based infant formula.
- The company has significantly reduced operating expenses by almost 60% year over year, contributing to a narrowing of the operating loss.
- Else Nutrition is engaging in partnership discussions with large companies for potential commercial distribution and strategic R&D collaboration, validating the brand's strength and global demand.
- The company experienced a revenue decline in Q2 2025 compared to Q2 2024, primarily due to inventory constraints and out-of-stock situations.
- Gross profit for the quarter was a loss, with a negative gross margin of minus 3.7%, driven by lower sales volumes and higher production costs.
- Else Nutrition faced reporting delays, which impacted investor trust, although steps are being taken to align reporting processes with regulatory timelines.
- Cash flow constraints have delayed the full commercial rollout of the adult ready-to-drink line, impacting potential revenue growth.
- The company is still operating under a cease trade order, although steps are being taken to address regulatory challenges and resume trading.
Greetings and welcome to Else Nutrition second quarter conference call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Alexandra Schilt. Thank you may begin.
Good morning and thank you for joining Else Nutrition's 2025 second quarter financial results and business update Conference call. On the call with us today is Hamatal Yitzhak, Chief Executive Officer of Else Nutrition.
The company issued a press release today containing its 2025 second quarter financial results, which is also posted on the company's website. If you have any questions after the call or would like any additional information about the company, please contact Crescendo Communications at 212-671-1020. The company's management will now provide prepared remarks reviewing the financial and operational results for the second quarter ended June 30, 2025.
Before we get started, we would like to remind everyone that today's call
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

